Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease

BACKGROUND/AIMS: Cognitive impairment, which frequently occurs in patients with schizophrenia, bipolar disorder, Alzheimer’s disease, and Parkinson’s disease, has a significant impact on the daily lives of both patients and their family. Furthermore, since the medications used for cognitive enhancem...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Wen-Yu, Lane, Hsien-Yuan, Lin, Chieh-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893641/
https://www.ncbi.nlm.nih.gov/pubmed/29670547
http://dx.doi.org/10.3389/fpsyt.2018.00091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893641/
https://www.ncbi.nlm.nih.gov/pubmed/29670547
http://dx.doi.org/10.3389/fpsyt.2018.00091

Ejemplares similares